loading
Precedente Chiudi:
$2.29
Aprire:
$2.2
Volume 24 ore:
1.91M
Relative Volume:
1.65
Capitalizzazione di mercato:
$26.94M
Reddito:
-
Utile/perdita netta:
$-23.36M
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+6.97%
1M Prestazione:
+90.27%
6M Prestazione:
-8.90%
1 anno Prestazione:
-87.35%
Intervallo 1D:
Value
$2.02
$2.29
Intervallo di 1 settimana:
Value
$2.02
$2.51
Portata 52W:
Value
$0.73
$26.30

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name
Nome
Calidi Biotherapeutics Inc
Name
Telefono
(858) 794-9600
Name
Indirizzo
4475 Executive Drive, Suite 200, San Diego
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CLDI's Discussions on Twitter

Confronta CLDI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
CLDI 2.15 26.94M 0 -23.36M 0 0.00
VRTX 449.73 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.37 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 599.51 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.06 24.89B 3.30B -501.07M 1.03B 11.54

Calidi Biotherapeutics Inc Borsa (CLDI) Ultime notizie

pulisher
Nov 20, 2024

Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register

Nov 19, 2024
pulisher
Nov 18, 2024

Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 16, 2024

Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail

Nov 16, 2024
pulisher
Nov 15, 2024

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews

Nov 15, 2024
pulisher
Nov 15, 2024

SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow

Nov 15, 2024
pulisher
Nov 14, 2024

Calidi prices 4.4M shares at $1.69 in public offering - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock - The Manila Times

Nov 14, 2024
pulisher
Nov 13, 2024

Calidi announces common stock offering, no amount given - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Surges on 3Q Report, Retreats on Stock-Offer News - MarketWatch

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics plans stock offering - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics plans stock offering By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Calidi Biotherapeutics Advances with FDA Clearance and Funding - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Calidi Bio Gets FDA Nod for Brain Cancer Drug Trial Amid $5.1M Q3 Loss | CLDI Stock | CLDI Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 04, 2024

Calidi Biotherapeutics’ $2.1 Million Shares Offering - Global Legal Chronicle

Nov 04, 2024
pulisher
Nov 02, 2024

Contrasting BioCryst Pharmaceuticals (NASDAQ:BCRX) & Calidi Biotherapeutics (NYSE:CLDI) - Defense World

Nov 02, 2024
pulisher
Oct 31, 2024

CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 31, 2024
pulisher
Oct 29, 2024

Calidi Biotherapeutics’ (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program - Barchart

Oct 29, 2024
pulisher
Oct 25, 2024

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 25, 2024
pulisher
Oct 24, 2024

Calidi to present data supporting RTNova at upcoming conferences - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences - The Manila Times

Oct 24, 2024
pulisher
Oct 24, 2024

Calidi to sell 2.05M shares at $1.00 in registered direct offering - Yahoo Finance

Oct 24, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics stock tumbles on $2M securities offering - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 23, 2024

CLDI stock touches 52-week low at $0.95 amid sharp annual decline - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Why Calidi Biotherapeutics (CLDI) Stock Is Down 13% - Benzinga

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics secures $2 million in equity financing - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement - The Manila Times

Oct 23, 2024
pulisher
Oct 19, 2024

Calidi Biotherapeutics Faces Warrant Delisting by NYSE - Yahoo Finance

Oct 19, 2024
pulisher
Oct 19, 2024

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS) - The Manila Times

Oct 19, 2024
pulisher
Oct 18, 2024

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire

Oct 18, 2024
pulisher
Oct 17, 2024

Exchange Income Corp (EIF-T) QuotePress Release - The Globe and Mail

Oct 17, 2024
pulisher
Oct 16, 2024

Cocoa #7 (CAU21) Quote - The Globe and Mail

Oct 16, 2024
pulisher
Oct 13, 2024

Wendy Pizarro - Los Angeles Times

Oct 13, 2024
pulisher
Oct 11, 2024

CLDI stock touches 52-week low at $1 amid market challenges - Investing.com Canada

Oct 11, 2024
pulisher
Oct 10, 2024

Calidi Biotherapeutics Launches Public Stock Offering to Fund Corporate Growth | CLDI Stock News - StockTitan

Oct 10, 2024
pulisher
Oct 04, 2024

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Oct 04, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial - TipRanks

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 - U.S. Politics Today

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma - The Manila Times

Sep 30, 2024
pulisher
Sep 30, 2024

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application - The Bakersfield Californian

Sep 30, 2024
pulisher
Sep 24, 2024

Calidi Biotherapeutics announces board changes and auditor ratification - Investing.com

Sep 24, 2024
pulisher
Sep 12, 2024

Calidi Biotherapeutics Presents Antitumor Virotherapy Advances - TipRanks

Sep 12, 2024

Calidi Biotherapeutics Inc Azioni (CLDI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):